España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Qiagen
QGEN
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$39.57
1.00
2.59%
At close: -
$39.57
0.00
0.00%
After Hours: Feb 21, 4:00 PM EDT
Get Report
Comment
Qiagen (QGEN) Forecast
News
Earnings
Qiagen (QGEN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Qiagen (NYSE:QGEN) Stock
Qiagen Stock (NYSE: QGEN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 19, 2025
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Avi Kapoor
Baird Downgrades Qiagen to Neutral, Lowers Pr...
Benzinga Newsdesk
Friday, February 07, 2025
UBS Maintains Neutral on Qiagen, Lowers Price...
Benzinga Newsdesk
Wednesday, February 05, 2025
Qiagen Earnings Review: Q4 Summary
Benzinga Insights
Qiagen Q4 Earnings Report: What Investors Need to Know
Benzinga Insights
Insights into Qiagen Q4 Earnings
Benzinga Insights
Qiagen: Q4 Earnings Insights
Benzinga Insights
Earnings Summary: Qiagen Q4
Benzinga Insights
Earnings Scheduled For February 5, 2025
Benzinga Insights
Tuesday, February 04, 2025
QIAGEN Wins German Patent Dispute Against SD ...
Benzinga Newsdesk
Thursday, January 16, 2025
Qiagen Announces $300M Capital Return Via Syn...
Benzinga Newsdesk
Sunday, January 12, 2025
Qiagen Said Sunday, It Will Return ~$300M To ...
Benzinga Newsdesk
Friday, January 10, 2025
QIAGEN Enhances QIAcuity Digital PCR With Hig...
Benzinga Newsdesk
Reported Earlier, QIAGEN Gains FDA Clearance ...
Benzinga Newsdesk
Monday, January 06, 2025
Morgan Stanley Downgrades Qiagen to Equal-Wei...
Benzinga Newsdesk
Thursday, December 12, 2024
QIAGEN Launches AI-Extension Of Ingenuity Pat...
Benzinga Newsdesk
Tuesday, December 10, 2024
Jefferies Assumes Qiagen at Buy, Raises Price...
Benzinga Newsdesk
Thursday, December 05, 2024
QIAGEN Achieves Milestone With Over 1,000 Pla...
Benzinga Newsdesk
Friday, November 29, 2024
Reported Thursday, QIAGEN Boosts QIAstat-Dx W...
Benzinga Newsdesk
Monday, November 18, 2024
Syros Pharmaceuticals Gave Notice To Qiagen M...
Benzinga Newsdesk
Tuesday, November 12, 2024
QIAGEN Collaborates With McGill University On...
Benzinga Newsdesk
Wednesday, November 06, 2024
QIAGEN Reaffirms FY24 Sales Of At Least $1.98...
Benzinga Newsdesk
Qiagen Q3 Adj $0.57 Beats $0.54 Estimate, Sal...
Benzinga Newsdesk
Monday, November 04, 2024
QIAGEN Gains FDA Clearance For Rapid QIAstat-...
Benzinga Newsdesk
Tuesday, October 29, 2024
QIAGEN Secures FDA Clearance For Qiastat-Dx M...
Benzinga Newsdesk
Thursday, October 17, 2024
HSBC Downgrades Qiagen to Hold
Benzinga Newsdesk
Thursday, October 10, 2024
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
Piero Cingari
QIAGEN Reveals Key Updates To Its Sample Tech...
Benzinga Newsdesk
Monday, September 30, 2024
QIAGEN Launches QIAcuityDx Digital PCR System...
Benzinga Newsdesk
Thursday, September 26, 2024
QIAGEN Receives European IVDR Certification F...
Benzinga Newsdesk
Wednesday, September 25, 2024
QIAGEN And BD Joint Venture, PreAnalytiX, Lau...
Benzinga Newsdesk
Monday, September 23, 2024
QIAGEN, Bode Technology Enter Multi-year Agre...
Benzinga Newsdesk
Wednesday, September 18, 2024
QIAGEN Expands QIAcuity Digital PCR Offering ...
Benzinga Newsdesk
Friday, September 13, 2024
Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance?
Zacks
Thursday, September 12, 2024
QIAGEN Expands Strategic Partnership With Bio...
Benzinga Newsdesk
Wednesday, September 04, 2024
QIAGEN Enters Collaboration With Eli Lilly To...
Benzinga Newsdesk
Wednesday, August 28, 2024
QIAGEN Expands Master Collaboration Agreement...
Benzinga Newsdesk
Friday, August 02, 2024
Baird Maintains Outperform on Qiagen, Raises ...
Benzinga Newsdesk
Wednesday, July 31, 2024
Qiagen Sees FY24 EPS $2.16 Vs $2.12 Est.; Rev...
Benzinga Newsdesk
Qiagen Q2 Adj $0.55 Beats $0.51 Estimate, Sal...
Benzinga Newsdesk
Monday, July 08, 2024
QIAGEN Announces Partnership With The Snow Mo...
Benzinga Newsdesk
Friday, June 28, 2024
QIAGEN Backs New AAP Guidelines Supporting QFT-Plus Test
Zacks
Thursday, June 27, 2024
Wolfe Research Upgrades Qiagen to Outperform,...
Benzinga Newsdesk
Monday, June 24, 2024
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation
Vandana Singh
Friday, June 21, 2024
CORRECTION : JP Morgan Maintains Overweight o...
Benzinga Newsdesk
Thursday, June 20, 2024
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Tuesday, June 18, 2024
JP Morgan Maintains Overweight on Qiagen, Rai...
Benzinga Newsdesk
Monday, June 17, 2024
Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches
Vandana Singh
Qiagen CEO Says Other Smaller Low-margin Prod...
Benzinga Newsdesk
QIAGEN Plans To Achieve At Least 31% CER Adju...
Benzinga Newsdesk
Show More
